IP Library Granted Patent US 10,464,972
Granted Patent B2
US 10,464,972 · App. 16/169,376 · Granted Nov 5, 2019

Multimer of mutant protein A and methods of using same

Inventors: Hong Qian (Nanjing, CN); Tao Bai (Nanjing, CN); Rong Hua (Nanjing, CN)
Assignee: Nanjingjinsirui Science & Technology Biology Corp.
C07K14/31C07K1/22C07K16/00G01N33/6854C07K2319/21C07K2319/705
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,464,972
App. No.
16/169,376
Granted
Nov 5, 2019
Kind
B2
Abstract

A series of protein A mutants having high alkali resistance, and methods of using the protein A mutants are provided. The protein A mutants have a high binding affinity for regions of immunoglobulin proteins other than the complementarity determining regions. The protein A mutants can be coupled to a solid support for immunoglobulin isolation, or conjugated to a label for immunoglobulin detection. This series of protein A mutants have high chemical stability under alkaline conditions of pH 13-14, and can also be used as chromatography ligands for purification procedures that use alkaline solutions under harsh conditions, such as Clean-In-Place (CIP). Also provided are methods of immunoglobulin separation and purification, and alkali regeneration of affinity chromatography medium that uses protein A as a ligand.

Claims (8)

1. A multimer of a recombinantly expressed mutant protein A molecule comprising at least two recombinant expressed mutant protein A molecules for isolating, purifying, or detecting an immunoglobulin, the mutant protein A molecule comprising the amino acid sequence of SEQ ID NO:1, the amino acid sequence of SEQ ID NO:2, the amino acid sequence of residues 7 to 54 of SEQ ID NO:1, or the amino acid sequence of residues 7 to 54 of SEQ ID NO:2.

2. The multimer of claim 1 , wherein the mutant protein A molecule is stable under alkaline conditions of pH 13-14.

3. The multimer of claim 1 , wherein the at least two recombinantly expressed mutant protein A molecules comprise the same amino acid sequence.

4. The multimer of claim 3 , wherein the multimer is a dimer, trimer, or tetramer comprising two, three, or four protein A mutants, respectively.

5. The multimer of claim 3 , wherein the one or more protein A mutants are linked together via one or more linker units comprising 4 to 10 amino acids.

6. The multimer of claim 5 , wherein the linker unit comprises the amino acid sequence ADGK (SEQ ID NO: 56).

7. The multimer of claim 3 , further comprising six histidine residues fused to the N-terminal end of the multimer.

8. The multimer of claim 7 , comprising the amino acid sequence of SEQ ID NO: 10 or SEQ ID NO: 12.

Assignments (3)
CHANGE OF NAME Recorded Apr 9, 2021
From: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
To: NANJING GENSCRIPT BIOTECH CO., LTD.
Reel/Frame 055886/0741 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE DATA PREVIOUSLY RECORDED ON REEL 047297 FRAME 0033. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Feb 20, 2019
From: QIAN, HONG; BAI, TAO; HUA, RONG
To: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
Reel/Frame 048379/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2018
From: QIAN, HONG; BAI, TAO; HUA, RONG
To: NANJING GENSCRIPT CO., LTD.
Reel/Frame 047297/0033 →
Priority Claims (1)
CN 2013 1 0087284 · Mar 18, 2013 · national
Continuity (2)
Division 14778395
Related Publication 20190048046A1 · Feb 14, 2019